Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.
Muratori, F., Mondanelli, N., Prifti, X., Scoccianti, G., Roselli, G., Frenos, F., et al. (2020). Total femur prosthesis in oncological and not oncological series. Survival and failures. JOURNAL OF ORTHOPAEDICS, 17, 215-220 [10.1016/j.jor.2019.11.009].
Total femur prosthesis in oncological and not oncological series. Survival and failures
Mondanelli N.;
2020-01-01
Abstract
Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.
| File | Dimensione | Formato | |
|---|---|---|---|
|
J Orthop 2020 total femur.pdf
non disponibili
Descrizione: Articolo
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
889.24 kB
Formato
Adobe PDF
|
889.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1272655